Microfluidic point-of-care (POC) devices in early diagnosis: A review of opportunities and challenges
SM Yang, S Lv, W Zhang, Y Cui - Sensors, 2022 - mdpi.com
The early diagnosis of infectious diseases is critical because it can greatly increase recovery
rates and prevent the spread of diseases such as COVID-19; however, in many areas with …
rates and prevent the spread of diseases such as COVID-19; however, in many areas with …
Microfluidic systems for infectious disease diagnostics
T Lehnert, MAM Gijs - Lab on a Chip, 2024 - pubs.rsc.org
Microorganisms, encompassing both uni-and multicellular entities, exhibit remarkable
diversity as omnipresent life forms in nature. They play a pivotal role by supplying essential …
diversity as omnipresent life forms in nature. They play a pivotal role by supplying essential …
[HTML][HTML] Microfluidics as a novel technique for tuberculosis: from diagnostics to drug discovery
Tuberculosis (TB) remains a global healthcare crisis, with an estimated 5.8 million new
cases and 1.5 million deaths in 2020. TB is caused by infection with the major human …
cases and 1.5 million deaths in 2020. TB is caused by infection with the major human …
Lab‐on‐a‐Chip Devices for Point‐of‐Care Infectious Diseases Diagnostics
The human species is vulnerable to the attack of deadly pathogens and needs continued
protection with successful and sustainable clinical approaches. The approach should be …
protection with successful and sustainable clinical approaches. The approach should be …
and Sushma Dave5 ¹Amity University Madhya Pradesh, Amity School of Pure & Applied Sciences, Department of Physics, Maharajpura Dang, Gwalior, Madhya …
S Jani¹, V Dave, M Pandya… - Point-of-Care Biosensors …, 2023 - books.google.com
An unhealthy lifestyle is dominant form of present modern lifestyle which leads a human
community toward the biggest challenges of infectious diseases in the coming time. In the …
community toward the biggest challenges of infectious diseases in the coming time. In the …
[PDF][PDF] Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery. Microorganisms 2021, 9, 2330
Tuberculosis (TB) remains a global healthcare crisis, with an estimated 5.8 million new
cases and 1.5 million deaths in 2020. TB is caused by infection with the major human …
cases and 1.5 million deaths in 2020. TB is caused by infection with the major human …
The Need for New Weapons in the Fight Against Drug-Resistant Tuberculosis
G Abel - The Journal of Applied Laboratory Medicine, 2020 - academic.oup.com
The article in this issue of JALM—Light Forge: A Microfluidic DNA Melting-Based
Tuberculosis Test—introduces a novel microfluidic highresolution melting analysis (HRMA) …
Tuberculosis Test—introduces a novel microfluidic highresolution melting analysis (HRMA) …